Artificial Intelligence/Machine Learning Medical Device Market Size, Share & Trends Analysis Report By Product Type (System/Hardware, Software-as-a-Medical Device), Application (Radiology, Cardiology, Hematology) And Segment Forecasts, 2025-2034
The Artificial Intelligence/Machine Learning Medical Device Market Size is valued at 6.10 Billion in 2024 and is predicted to reach 52.09 Billion by the year 2031 at a 24.1% CAGR during the forecast period for 2024-2031.

The market for artificial intelligence/machine learning-enabled medical devices is very fragmented, and each year, more products bearing the FDA and CE marks are approved. Due to continuous technical advancements and investments in healthcare AI, this industry still has a substantial amount of growth potential. The advancement of AI-based medical devices that enable diagnostic accuracy and productivity present a potential opportunity for the worldwide artificial intelligence/machine learning medical device market.
The market is anticipated to develop quickly following the COVID-19 pandemic, mostly because of the increasing use of AI-based solutions brought on by the epidemic. The market will grow because of an increase in research into AI-enabled products, improvements in deep learning and machine learning algorithms, the release of new products onto the market, the emergence of regional businesses, and the expanding use of AI-based products for therapeutic purposes.
Recent Developments:
- In Nov 2021, Nano-X Imaging Ltd announced merger with Zebra Medical Vision, Ltd. had been completed. This strategic merger complements Nanox's deep learning technology and Nanox's product line.ARC System helps the company realize its vision of democratizing healthcare worldwide. This acquisition is another step towards the company's goal of democratising healthcare delivery. Nanox integrates AI-driven image analysis and a global teleradiology solution. The ARC technology brings company one step closer to a global, connected medical imaging solution with the potential to expand healthcare delivery significantly.
Competitive Landscape:
Some of the Artificial Intelligence/Machine Learning Medical Device Market players are:
- CellaVision AB;
- Canon Inc.;
- Clarius Mobile Health Corp.
- General Electric Company;
- Aidoc Medical, Ltd.
- Koninklijke Philips N.V.,
- Hyperfine Inc.,
- Nanox.AI Ltd.,
- Medtronic Plc.,
- Page.AI,
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Tempus
- Shanghai United Imaging Healthcare Co., Ltd.
- Viz.ai, Inc.
- AI4MedImaging Medical Solutions S.A.
- Ever Fortune.AI Co., Ltd.
- MedMind Technology Co., Ltd.
- AIRS Medical Inc.
- CU-BX Automotive Technologies Ltd.
- Annalise-AI
- AZmed SAS
- Smart Soft Healthcare AD
Market Segmentation:
The Artificial Intelligence/Machine Learning Medical Device Market is segmented based on product type, clinical area. The product type segment includes System/Hardware and Software-as-a-Medical Device. By Clinical Area application, the market is divided into Radiology, Cardiology, and Hematology. The radiology segment it is segmented (by Type) includes Diagnostic Assistance, Imaging, and Image Reconstruction. The cardiology segment (by Type) includes Electrocardiography-Based Arrhythmia Detection and Hemodynamics and Vital Signs Monitoring.
The Radiology Sector Is Anticipated To Lead The Worldwide Artificial Intelligence/Machine Learning Medical Device Market (By Clinical Area)
The market for AI/ML medical devices will lead in the clinical area segment for radiology. AI-enabled medical devices are being developed for various clinical applications, including radiology, cardiology, hematology, obstetrics, gastrointestinal, and pathology. AI in radiology can support radiologists in data interpretation and diagnostic confirmation. For a variety of tasks in radiology, including the identification of suspicious lesions, improving the quality of imaging, picture segmentation and contouring, and image reconstruction, artificial intelligence (AI) is being used.
North America held the largest market share in 2023
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America are the five geographic areas into which the worldwide market is divided. Significant R&D investors like Oracle Corporation, IBM Corporation, and Amazon.com increase the market size in the area. Furthermore, it is anticipated that substantial expenditures and the availability of existing IT infrastructure would fuel market expansion in North America.
Customers now have easier access to services and products that use AI, which impacts the regional economy. The European Union proposed a 10.4 billion USD budget for the Digital Europe Programme in June 2018 for the years 2021–2027. Over the course of the prediction, Asia Pacific is anticipated to advance at a speedier rate. A lively and robust startup ecosystem is present in the area's rising economies, including China, India, and the Philippines. An expanding trained labor force that fuels regional market expansion aids this ecosystem.
Artificial Intelligence/Machine Learning Medical Device Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2024 | USD 6.10 Bn |
| Revenue forecast in 2034 | USD 52.09 Bn |
| Growth rate CAGR | CAGR of 24.1% from 2025 to 2034 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Product Type, Clinical Area |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Japan; South Korea; Southeast Asia |
| Competitive Landscape | Aidoc Medical, Ltd., Canon Inc., CellaVision AB, Clarius Mobile Health Corp., General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., Medtronic plc, Nanox.AI Ltd., Paige.AI |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Artificial Intelligence/Machine Learning Medical Device Market-
Artificial Intelligence/Machine Learning Medical Device Market By Product Type-
- System/Hardware
- Software-as-a-Medical Device
Artificial Intelligence/Machine Learning Medical Device Market By Clinical Area-
- Radiology
- Diagnostic Assistance
- Imaging
- Image Reconstruction
- Cardiology
- Electrocardiography-Based Arrhythmia Detection
- Hemodynamics and Vital Signs Monitoring
- Hematology
- Others
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Artificial Intelligence/Machine Learning Medical Device Market Size is valued at 6.10 Billion in 2024 and is A predicted to reach 52.09 Billion by the
Artificial Intelligence/Machine Learning Medical Device Market expected to grow at a 24.1% CAGR during the forecast period for 2025-2034
Aidoc Medical, Ltd., Canon Inc., CellaVision AB, Clarius Mobile Health Corp., General Electric Company, Hyperfine Inc., Koninklijke Philips N.V.
Artificial Intelligence/Machine Learning Medical Device Market is segmented based on product type, clinical area.
North American region is leading the Artificial Intelligence/Machine Learning Medical Device Market.